Document is current
Any future updates will be listed below
-
Authors
Siegmund, Sophie C. https://orcid.org/0009-0003-3175-952X
Holzgreve, Adrien
Schöll, Magdalena
Wenter, Vera U.
Sheikh, Gabriel T.
Scheifele, Maximilian
Gildehaus, Franz Josef
Lindner, Simon
Auer, Matthias K.
Lottspeich, Christian
Kroiß, Matthias
Nölting, Svenja
Völter, Friederike
Spitzweg, Christine
Auernhammer, Christoph J.
Werner, Rudolf A.
Zacherl, Mathias J.
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 22 July 2025
Accepted: 25 August 2025
First Online: 19 September 2025
Declarations
:
: The analysis was performed in compliance with the principles of the Declaration of Helsinki and was approved by the institutional ethics committee of the Ludwig-Maximilians-University of Munich (IRB #21–0102 and #24–0982).
: Not applicable.
: AH: Personal fees from ABX advanced biochemical compounds. RAW: speaker honoraria from Novartis/AAA and PentixaPharm, advisory board work for Novartis/AAA and Bayer. MJZ: speaker honoraria from Novartis, SIRTEX and Terumo, advisory board for Boston Scientific. MKA: speaker honoria from AstraZeneca.
